The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Effect of Estrogen Therapy on Gallbladder Disease
Open accessAbstract
CONTEXT: Estrogen therapy is thought to promote gallstone formation and cholecystitis but most data derive from observational studies rather than randomized trials. OBJECTIVE: To determine the effect of estrogen therapy in healthy postmenopausal women on gallbladder disease outcomes. DESIGN, SETTING, AND PARTICIPANTS: Two randomized, double-blind, placebo-controlled trials conducted at 40 US clinical centers. The volunteer sample was 22,579 community-dwelling women aged 50 to 79 years without prior cholecystectomy. INTERVENTION: Women with hysterectomy were randomized to 0.625 mg/d of conjugated equine estrogens (CEE) or placebo (n = 8376). Women without hysterectomy were randomized to estrogen plus progestin (E + P), given as CEE plus 2.5 mg/d of medroxyprogesterone acetate (n = 14,203). MAIN OUTCOME MEASURES: Participants reported hospitalizations for gallbladder diseases and gallbladder-related procedures, with events ascertained through medical record review. Cox proportional hazards regression was used to assess hazard ratios (HRs) and 95% confidence intervals (CIs) using intention-to-treat and time-to-event methods. RESULTS: The CEE and the E + P groups were similar to their respective placebo groups at baseline. The mean follow-up times were 7.1 years and 5.6 years for the CEE and the E + P trials, respectively. The annual incidence rate for any gallbladder event was 78 events per 10,000 person-years for the CEE group (vs 47/10,000 person-years for placebo) and 55 per 10,000 person-years for E + P (vs 35/10,000 person-years for placebo). Both trials showed greater risk of any gallbladder disease or surgery with estrogen (CEE: HR, 1.67; 95% CI, 1.35-2.06; E + P: HR, 1.59; 95% CI, 1.28-1.97). Both trials indicated a higher risk for cholecystitis (CEE: HR, 1.80; 95% CI, 1.42-2.28; E + P: HR, 1.54; 95% CI 1.22-1.94); and for cholelithiasis (CEE: HR, 1.86; 95% CI, 1.48-2.35; E + P: HR, 1.68; 95% CI, 1.34-2.11) for estrogen users. Also, women undergoing estrogen therapy were more likely to receive cholecystectomy (CEE: HR, 1.93; 95% CI, 1.52-2.44; E + P: HR, 1.67; 95% CI, 1.32-2.11), but not other biliary tract surgery (CEE: HR, 1.18; 95% CI, 0.68-2.04; E + P: HR, 1.49; 95% CI, 0.78-2.84). CONCLUSIONS: These data suggest an increase in risk of biliary tract disease among postmenopausal women using estrogen therapy. The morbidity and cost associated with these outcomes may need to be considered in decisions regarding the use of estrogen therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Design of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
Postmenopausal Hormone Replacement Therapy: Scientific Review
Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., & Allan, J. D. (2002) · JAMA · doi:10.1001/jama.288.7.872 · Cited by 990
Implementation of the women's health initiative study design
Anderson, G. L., Manson, J., Wallace, R., Lund, B., Hall, D., Davis, S., Shumaker, S., Wang, C.-Y., Stein, E., & Prentice, R. L. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00043-7 · Cited by 756
Ambulatory and inpatient procedures in the United States, 1994.
Pokras, R., Kozak, L. J., & McCarthy, E. (1997) · PubMed · Cited by 436
the Boston Collaborative Drug Surveillance Program, B. U. M. C. (1974) · New England Journal of Medicine · doi:10.1056/nejm197401032900104 · Cited by 345
Ambulatory and inpatient procedures in the United States, 1995.
Kozak, L. J., & Owings, M. F. (1998) · PubMed · Cited by 300
Stefanick, M. L., Cochrane, B. B., Hsia, J., Barad, D. H., Liu, J. H., & Johnson, S. R. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00045-0 · Cited by 232
Postmenopausal hormone use and cholecystectomy in a large prospective study.
Grodstein, F., Colditz, G. A., & Stampfer, M. J. (1994) · PubMed · Cited by 124
Simon, J. A., Hunninghake, D. B., Agarwal, S. K., Lin, F., Cauley, J. A., Ireland, C. C., & Pickar, J. H. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-7-200110020-00008 · Cited by 98
Hyperinsulinemia, Dyslipidemia, and Obesity as Risk Factors for Hospitalized Gallbladder Disease
Boland, L. L., Folsom, A. R., & Rosamond, W. D. (2002) · Annals of Epidemiology · doi:10.1016/s1047-2797(01)00260-5 · Cited by 91
Jørgensen, T. (1988) · Gut · doi:10.1136/gut.29.4.433 · Cited by 91
PHYSICAL AND METABOLIC FACTORS IN GALLSTONE PATHOGENESIS
Donovan, J. M. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70044-3 · Cited by 76
Management of gallstones and their complications.
Ahmed, A., Cheung, R. C., & Keeffe, E. B. (2000) · PubMed · Cited by 68
Uhler, M. L., Marks, J. W., Voigt, B. J., & Judd, H. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4596 · Cited by 49
Postmenopausal estrogen replacement therapy and increased rates of cholecystectomy and appendectomy.
Mamdani, M., Tu, K., van Walraven, C., Austin, P. C., & Naylor, C. D. (2000) · Europe PMC (PubMed Central) · Cited by 46
Non-contraceptive estrogen use and the risk of gallstone disease in women.
Kakar, F., Weiss, N. S., & STRITE, S. A. (1988) · American Journal of Public Health · doi:10.2105/ajph.78.5.564 · Cited by 38
Estrogen predisposes to cholecystectomy but not to stones
Everson, R. B., Byar, D. P., & Bischoff, A. J. (1982) · Gastroenterology · doi:10.1016/0016-5085(82)90114-7 · Cited by 37
Uhler, M. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.410 · Cited by 17
Cited by
Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer
Stinton, L. M., & Shaffer, E. A. (2012) · Gut and Liver · doi:10.5009/gnl.2012.6.2.172 · Cited by 1,381
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett-Connor, E., Mosca, L., Collins, P., Geiger, M. J., Grady, D., Kornitzer, M., McNabb, M. A., & Wenger, N. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062462 · Cited by 1,048
The 2017 hormone therapy position statement of The North American Menopause Society
(2017) · Menopause · doi:10.1097/gme.0000000000000921 · Cited by 1,001
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
Metadata
- Authors
- Cirillo, D. J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-01-19
- Volume
- 293
- Issue
- 3
- Pages
- 330
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2123973543
- Cited by
- 304
- References
- 20
- FWCI
- 9.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.